Advertisement

Topics

RET inhibition in RET aberrant cancers

07:43 EDT 10 Jul 2019 | ecancermedicalscience

Dr Vivek Subbiah speaks to ecancer at the WIN 2019 Symposium in Paris about RET inhibition in RET aberrant cancers. He explains that RET is an oncogenic driver seen in multiple cancers, most commonly lung cancers. Dr Subbiah discusses various RET...

Original Article: RET inhibition in RET aberrant cancers

NEXT ARTICLE

More From BioPortfolio on "RET inhibition in RET aberrant cancers"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Pulmonary
Pulmonary relating to or associated with the lungs eg Asthma, chronic bronchitis, emphysema, COPD, Cystic Fibrosis, Influenza,  Lung Cancer, Pneumonia, Pulmonary Arterial Hypertension, Sleep Disorders etc Follow and track Lung Cancer News ...